|
1
|
Hamad AWR, Ibrahim MA, Al-Mohtasib SI and
Al-Kobasi KN: Comparative study on saliva proteins in patients and
healthy individuals of brain tumours. Trends Med Res. 4:16–23.
2009.
|
|
2
|
Gast MC, Van Gils CH, Wessels LF, Harris
N, Bonfrer JM, Rutgers EJ, Schellens JH and Beijnen JH: Serum
protein profiling for diagnosis of breast cancer using SELDI-TOF
MS. Oncol Rep. 22:205–213. 2009.
|
|
3
|
Parkin DM, Muir CS, Whelan SL, et al:
Cancer Incidence in Five Continents. 6IARC Scientific Publications.
(120)Lyon: IARC; 1992
|
|
4
|
Colditz GA and Frazier AL: Models of
breast cancer show that risk is set by events of early life:
prevention efforts must shift focus. Cancer Epidemiol Biomarkers
Prev. 4:567–571. 1995.
|
|
5
|
MacMahon B: Epidemiology and the causes of
breast cancer. Int J Cancer. 118:2373–2378. 2006.
|
|
6
|
Yilmaz IA, Akçay T, Cakatay U, et al:
Relation between bladder cancer and protein oxidation. Int Urol
Nephrol. 35:345–350. 2003.
|
|
7
|
Santamaria-Kisiel L, Rintala-Dempsey AC
and Shaw GS: Calcium-dependent and -independent interactions of the
S100 protein family. Biochem J. 396:201–214. 2006.
|
|
8
|
Schipper RG, Silletti E and Vingerhoeds
MH: Salivary as research material: biochemical, physicochemical and
practical aspects. Arch Oral Biol. 52:1114–1135. 2007.
|
|
9
|
Lawrence HP: Salivary markers of systemic
disease: non-invasive diagnosis of disease and monitoring of
general health. J Can Dent Assoc. 68:170–174. 2002.
|
|
10
|
Rosen FS and Bailey BJ: Anatomy and
Physiology of the Salivary Glands, Grand Rounds Presentation. 5th
edition. UTMB; 2001
|
|
11
|
Lee YH and Wong DT: Saliva: an emerging
biofluid for early detection of diseases. Am J Dent. 22:241–248.
2009.
|
|
12
|
Choi M: Saliva diagnostics integrate
dentistry into general and preventive health care. Int J
Prosthodont. 23:1892010.
|
|
13
|
Kunsman K: Oral fluid testing arrives.
Occup Health Saf. 69:28–30. 2000.
|
|
14
|
Oppenheim FG, Salih E, Siquerira WL, Zhang
W and Helmerhorst EJ: Salivary proteome and its genetic
polymorphisms. Ann NY Acad. 1098:22–50. 2007.
|
|
15
|
Kazmi SH, Naglik JR, Sweet SP, et al:
Comparison of human immunodeficiency virus type 1-specific
inhibitory activities in saliva, and other human mucosal fluids.
Clin Vaccine Immunol. 13:1111–1118. 2006.
|
|
16
|
Pink R, Simek J, Vondrakova J, et al:
Saliva as a diagnostic medium. Biomed Pap Med Fac Univ Palacky
Olomouc Czrch Repub. 153:103–110. 2009.
|
|
17
|
Hofman LF: Human saliva as a diagnostic
specimen. J Nutr. 131:1621S–1625S. 2001.
|
|
18
|
Helmerhorst EJ and Oppenheim FG: Saliva: a
dynamic protecome. J Dent Res. 86:680–693. 2007.
|
|
19
|
Castagnola M, Cabras T, Vitali A, Sanna MT
and Messana I: Biotechnological implications of the salivary
protecome. Trends Biotechnol. 29:409–418. 2011.
|
|
20
|
Nishanian P, Aziz N, Chung J, Detels R and
Fahey JL: Oral fluids as an alternative to serum for measurement of
markers of immune activation. Clin Diagn Lab Immunol. 5:507–512.
1998.
|
|
21
|
Doumas BT, Bayse DD, Carter RJ, Peters T
Jr and Schaffer R: A candidate reference method for determination
of total protein in serum. I Development and validation. Clin Chem.
27:1642–1650. 1981.
|
|
22
|
National Committee for Clinical Laboratory
Standards. Specification for Standardized Protein Solution (Bovine
Serum Albumin). National Committee Standards for Clinical
Laboratory. 2nd edition. Villanova; Pennsylvania, PA: pp. 19–85.
1979
|
|
23
|
Khoury SA and Mas’ad DF: Profile of cancer
family clustering in Jordan. East Mediterr Health J. 14:1101–1109.
2008.
|
|
24
|
Arkoob K, Al-Nsour M, Al-Nemry O and
Al-Hajawi B: Epidemiology of breast cancer in women in Jordan:
patient characteristics and survival analysis. East Mediteer Health
J. 16:1032–1038. 2010.
|
|
25
|
Gao WM, Kuick R, Orchekowski RP, et al:
Distinctive serum protein profiles involving abundant proteins in
lung cancer patients based upon antibody microarray analysis. BMC
Cancer. 5:1102005.
|
|
26
|
Halliwell B: Antioxidants: the basics -
what they are and how to evaluate them. Adv Pharmacol. 38:3–20.
1997.
|
|
27
|
Jsiem RH, Hasan RH and Husain MK: A
biochemical study for evaluation and analysis of serum protein of
patients with different kidney tumors. J Baghdad for Sci.
9:311–321. 2012.
|
|
28
|
Al-Ardee R: Evaluation of sialic acid
levels and lectin activity as tumour markers for gynaecologic
cancers (unpublished PhD thesis). University of Kufa; 2001
|
|
29
|
Oztürk LK, Emekli-Alturfan E, Kaşikci E,
et al: Salivary total sialic acid levels increase in breast cancer
patients: a preliminary study. Med Chem. 7:443–447. 2011.
|
|
30
|
Yan W, Apweiler R, Balgley BM, et al:
Systematic comparison of the human saliva and plasma proteomes.
Proteomics Clin Appl. 3:116–134. 2009.
|
|
31
|
Haeckel R and Hänecke P: Application of
saliva for drug monitoring. An in vivo model for
transmembrane transport. Eur J Clin Chem Clin Biochem. 34:171–191.
1996.
|
|
32
|
Bigler LR, Streckfus CF and Dubinsky WP:
Salivary biomarkers for the detection of malignant tumors that are
remote from the oral cavity. Clin Lab Med. 29:71–85. 2009.
|
|
33
|
Kuerer M, Thompson PA, Krishnamurthy S, et
al: High and differential expression of HER-2/neu extracellular
domain in bilateral ductal fluids from women with unilateral
invasive breast cancer. Clin Cancer Res. 9:601–605. 2003.
|
|
34
|
Siqueira WL and Dawes C: The salivary
proteomics: challenges and perspectives. Proteomics Clin Appl.
5:575–579. 2011.
|
|
35
|
Kaplen LA and Pesce AJ: Clinical
Chemistry: Theory, Analysis and Correlation. 4th edition. C.V.
Mosby Co; St. Louis, MO: 2003
|
|
36
|
Henry JB: Clinical Diagnosis and
Management by Laboratory Methods. 20th edition. W.B. Saunders Co;
Philadelphia, PA: 2001
|
